The Journal of Immunology, Vol 143, Issue 10 3148-3156, Copyright © 1989 by American Association of Immunologists

ARTICLES

Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence of peptide-MHC interaction

DR Milich, JE Jones, A McLachlan, R Houghten, GB Thornton and JL Hughes
Department of Molecular Biology, Research Institute of Scripps Clinic, La Jolla, CA 92037.

One purpose of this study was to examine the concept of T cell immunodominance employing a neonatal tolerance model. The extent to which a single T cell recognition site can represent the total T cell response to hepatitis B core Ag (HBcAg) was examined in the B10.S and B10 murine strains. It was shown that the entire B10.S T cell response to HBcAg was focused on a single immunodominant site represented by residues 120-131. This was demonstrated by exposing B10.S neonatal mice to p120-140 or p120-131, which resulted in a state of T cell tolerance to the entire HBcAg. In contrast, p120-140 contained an immunogenic T cell site for B10 mice, p129-140, but this site was nontolerogenic. Similarly, injection of p120-140 into (B10.S X B10)F1 neonatal mice resulted in tolerization of p120-131-specific, I-As-restricted T cells, but not of p129-140-specific, I-Ab-restricted T cells. The second purpose of this study was to attempt to explain the immunologic basis of an immunogenic yet nontolerogenic T cell determinant. It was shown that the p120-131 T cell site, which is immunogenic and tolerogenic in B10.S mice, could be converted into an immunogenic/nontolerogenic T cell site by a single amino acid substitution in either residue 127 or 129. Residues 127 and 129 were previously shown to be involved in interaction with MHC class II molecules (agretopic). These results demonstrated that the relative avidity of a peptide-MHC interaction can influence T cell tolerance induction. Furthermore, the results suggest that a higher threshold of peptide-MHC avidity may be required to induce T cell tolerance as compared to the threshold of peptide-MHC avidity required to immunize T cells.

This article has been cited by other articles:

				M. Chen, M. Sallberg, J. Hughes, J. Jones, L. G. Guidotti, F. V. Chisari, J.-N. Billaud, and D. R. Milich Immune Tolerance Split between Hepatitis B Virus Precore and Core Proteins J. Virol., March 1, 2005; 79(5): 3016 - 3027. [Abstract] [Full Text] [PDF]

				D. V. Serreze, H. D. Chapman, C. M. Post, E. A. Johnson, W. L. Suarez-Pinzon, and A. Rabinovitch Th1 to Th2 Cytokine Shifts in Nonobese Diabetic Mice: Sometimes an Outcome, Rather Than the Cause, of Diabetes Resistance Elicited by Immunostimulation J. Immunol., January 15, 2001; 166(2): 1352 - 1359. [Abstract] [Full Text] [PDF]

				M. Chen, M. Sällberg, S. N. Thung, J. Hughes, J. Jones, and D. R. Milich Nondeletional T-Cell Receptor Transgenic Mice: Model for the CD4+ T-Cell Repertoire in Chronic Hepatitis B Virus Infection J. Virol., August 15, 2000; 74(16): 7587 - 7599. [Abstract] [Full Text]

				E. Dahlen, G. Hedlund, and K. Dawe Low CD86 Expression in the Nonobese Diabetic Mouse Results in the Impairment of Both T Cell Activation and CTLA-4 Up-Regulation J. Immunol., March 1, 2000; 164(5): 2444 - 2456. [Abstract] [Full Text] [PDF]

				R. I. Fox and H.-I. Kang Mechanism of Action of Antimalarial Drugs: Inhibition of Antigen Processing and Presentation Lupus, January 1, 1993; 2(1_suppl): S9 - S12. [Abstract] [PDF]